Status:
COMPLETED
Using Smart Phone Technology in Detecting the Presence of Atrial Fibrillation
Lead Sponsor:
The Cleveland Clinic
Collaborating Sponsors:
AliveCor
Conditions:
Atrial Fibrillation
Atrial Flutter
Eligibility:
All Genders
18-80 years
Brief Summary
The purpose of this study is to examine whether patients can use the AliveCor case to record their heart rhythm and to assess the accuracy of the software in detecting AF vs sinus rhythm
Detailed Description
AliveCor is a new monitoring technology used with a smart phone which allows patients to record their rhythm. The study will compare AliveCor recordings and automated interpretation of the rhythm with...
Eligibility Criteria
Inclusion
- Male or female between \> 18 and \< 80 years of age
- Paroxysmal or persistent atrial fibrillation
- Admitted for antiarrhythmic drug loading (Dofetilide or Sotalol)
- Already has iPhone 4, 4S or 5 with data plan that accommodates the AliveCor case
- Willing to use the Alive Cor case
- Written informed consent
Exclusion
- Unable or unwilling to use the Alive Cor case for their smart phone
- Presence of a permanent pacemaker
Key Trial Info
Start Date :
August 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2017
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT02214069
Start Date
August 1 2014
End Date
July 1 2017
Last Update
December 13 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cleveland Clinic
Cleveland, Ohio, United States, 44195